Clinical trial
Characterizing Longitudinal Outcomes in Adults With SMA Treated With Nusinersen
NCT04591678 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterizing Longitudinal Outcomes in Adults With SMA Treated With Nusinersen
- Lead sponsor
- Ohio State University
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- June 25, 2021
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal muscular atrophy